alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 2,501–2,525 of 7,816 matching trials · page 101 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
SHARPEN - Parkinson's Disease Dementia
NCT05987540
Non-invasive brainstem stimulation
Runs in: United States · 2 sites 		NA
other		 TERMINATED 9 Scion NeuroStim
INDUSTRY		 2025-05-09
Evaluation of the Effect of Healthy Lifestyle Intervention for Patients With Mild Cognitive Impairment
NCT06942780
Exercise intervention; Social intervention; Dietary intervention; C...
Runs in: China · 1 site 		NA
other		 NOT_YET_RECRUITING 30 Xuanwu Hospital, Beijing
OTHER		 2025-05-09
Validation Study of a New Digital Diagnostic and Treatment Test Based on Interactive Video Games for Alzheimer's Disease
NCT06963879
Bgaze Therapy; Bgaze Attention Task
Runs in: Spain · 1 site 		NA
other		 ENROLLING_BY_INVITATION 60 Braingaze
INDUSTRY		 2025-05-09
A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects
NCT06964230
T3D-959; Placebo Comparator
Runs in: United States · 1 site 		PHASE2|PHASE3
other		 NOT_YET_RECRUITING 376 T3D Therapeutics, Inc.
INDUSTRY		 2025-05-09
4 Repeat Tauopathy Neuroimaging Initiative
NCT01804452
Observational Study
Runs in: United States · 2 sites 		NA
other		 COMPLETED 110 University of California, San Francisco
OTHER		 2025-05-08
Imaging Tau in Alzheimer's Disease and Normal Aging
NCT03373604
18F-MK-6240; Lumbar Puncture (optional)
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 71 Patrick Lao
OTHER		 2025-05-08
MASCoD - Multidimensional Assessment of Subjective Cognitive Decline
NCT05815329
cognitive training
Runs in: Italy · 1 site 		NA
other		 RECRUITING 100 Istituti Clinici Scientifici Maugeri SpA
OTHER		 2025-05-08
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
NCT06089161
Standard of Care; Personalized OSA Treatment
Runs in: United States · 1 site 		NA
other		 RECRUITING 330 University of Miami
OTHER		 2025-05-08
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
NCT06613971
Runs in: United States · 1 site 		NA
other		 RECRUITING 50 MD Stem Cells
INDUSTRY		 2025-05-08
Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients
NCT02085265
Perindopril; Telmisartan
Runs in: Canada · 10 sites 		PHASE2
other		 TERMINATED 23 Sunnybrook Health Sciences Centre
OTHER		 2025-05-06
Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
NCT03389100
18F-MK6240 injection
Runs in: United States · 1 site 		PHASE2
other		 ENROLLING_BY_INVITATION 600 Columbia University
OTHER		 2025-05-06
Learning and Improving Alzheimer's Patient-Caregiver Relationships Via Smart Healthcare Technology
NCT04536701
Mood Monitoring and Behavioral Recommendation System
Runs in: United States · 1 site 		NA
other		 COMPLETED 22 Ohio State University
OTHER		 2025-05-06
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
NCT04500847
Emtriva Capsule; Placebo
Runs in: United States · 2 sites 		PHASE1
other		 UNKNOWN 35 Butler Hospital
OTHER		 2025-05-04
Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment
NCT06951932
Mediterranean-type diet with MCT supplementation; Mediterranean-typ...
Runs in: Italy · 1 site 		NA
other		 RECRUITING 120 Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
OTHER		 2025-05-04
Caregiver Outcomes of Alzheimer's Disease Screening
NCT03300180
Collaborative Dementia Care Program; Screening Only
Runs in: United States · 2 sites 		NA
other		 COMPLETED 1,822 Indiana University
OTHER		 2025-05-02
Brain Health Support Program
NCT05347966
Brain Health PRO
Runs in: Canada · 7 sites 		NA
other		 COMPLETED 354 Baycrest
OTHER		 2025-05-02
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
NCT05395624
18F-OP-801
Runs in: United States · 3 sites 		PHASE1|PHASE2
other		 RECRUITING 65 Ashvattha Therapeutics, Inc.
INDUSTRY		 2025-05-02
A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease
NCT05644977
Emraclidine; Placebo
Runs in: United States · 11 sites 		PHASE1
other		 COMPLETED 17 AbbVie
INDUSTRY		 2025-05-02
Medication Repurposing to Stop Cognitive Decline in Dementia
NCT05817188
No intervention
Runs in: Sweden · 1 site 		NA
other		 COMPLETED 100,000 Karolinska Institutet
OTHER		 2025-05-02
The Effects of Specific tDCS on Cognition in MCI
NCT05919485
tDCS
Runs in: Turkey (Türkiye) · 1 site 		NA
other		 RECRUITING 120 Istanbul Medipol University Hospital
OTHER		 2025-05-02
Prediction of Effectiveness of rTMS Application in Alzheimer's Patients
NCT05977088
Repetetive Transcranial Magnetic Stimulation
Runs in: Turkey (Türkiye) · 1 site 		NA
other		 RECRUITING 40 Istanbul Medipol University Hospital
OTHER		 2025-05-02
Statins, Cholesterol and Cognitive Decline in Alzheimer's
NCT06635252
STA 4783
Runs in: Sweden · 1 site 		NA
other		 COMPLETED 2,000 Karolinska Institutet
OTHER		 2025-05-02
EARLY-COGN^3 - Smart Digital Solutions for EARLY Treatment of COGnitive Disability: a Neuropsychological, Neurophysiological and Neurobiological Perspective in Chronic Neurological Diseases - PNRR-MCNT2-2023-12377069
NCT06657274
RICORDO-DTx; Home-based unstructured cognitive stimulation
Runs in: Italy · 3 sites 		NA
other		 RECRUITING 60 IRCCS Centro San Giovanni di Dio Fatebenefratelli
OTHER		 2025-05-02
Effects of Brain Beta-Amyloid on Postoperative Cognition
NCT01606488
Florbetapir F 18 (18F-AV-45); no intervention
Runs in: United States · 1 site 		PHASE4
other		 ACTIVE_NOT_RECRUITING 66 University of California, San Francisco
OTHER		 2025-05-01
ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders
NCT02252380
Transcranial ExAblate System
Runs in: Canada · 2 sites 		NA
other		 ACTIVE_NOT_RECRUITING 10 InSightec
INDUSTRY		 2025-05-01

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →